Skip to main content
Clinical Trials/CTRI/2024/04/066396
CTRI/2024/04/066396Not yet recruitingNot Applicable

A Descriptive study of Adverse Drug Reactions with Causality Assessment and Potential Drug Interactions in the Outpatients of the Psychiatric Department at SMS Hospital Jaipur.

Dr. Kapil Goyal1 site in 1 country600 target enrollmentStarted: May 6, 2024Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
600
Locations
1
Primary Endpoint
1. To report and evaluate patterns of Adverse Drug Reactions (ADRs) occurring due

Study Overview

Brief Summary

Under-reporting is a problem with ADRs occurring due to psychotropic drugs. The need for this study is for observation and analysis of the ADRs occurring due to psychotropic drugs and then assessing all the reported ADRs for Causality using World Health Organization-Uppsala Monitoring Centre (WHO-UMC) scale. Also, studying the potential drug-drug interactions (pDDIs) amongst different psychotropic drugs as well as between psychotropic drugs and other co-prescribed drugs by using Medscape software (online) (http://reference.medscape.com/drug-interactionchecker) will aid clinicians to achieve optimal therapeutic outcomes in patients by increasing awareness of clinically relevant psychotropic drug interactions. It will also help to sensitize the healthcare workers as well as the patients and their attendant for reporting of ADRs occurring due to psychotropic medications.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Patients attending the Psychiatric OPD for follow up, who were diagnosed to be suffering from any psychiatric illness and prescribed at least one psychotropic drug.
  • Patients of either sex.
  • Patients in the age group of 18 years to 60 years.
  • Patients who will give informed consent.

Exclusion Criteria

  • Patients having mental and behavioural disorders due to psychoactive substance use.
  • Patients who are pregnant/ lactating women.
  • Patients who are part of any other study.
  • Patients who will be non-co-operative.

Outcomes

Primary Outcomes

1. To report and evaluate patterns of Adverse Drug Reactions (ADRs) occurring due

Time Frame: 6 Months

to psychotropic drugs.

Time Frame: 6 Months

2. To assess all the reported ADRs for Causality using WHO-UMC scale.

Time Frame: 6 Months

3. To study the potential drug-drug interactions (pDDIs) among different

Time Frame: 6 Months

psychotropic drugs as well as between psychotropic drugs and other co-prescribed

Time Frame: 6 Months

drugs by using Medscape software (online) (http://reference.medscape.com/druginteractionchecker).

Time Frame: 6 Months

Secondary Outcomes

  • 1. To process the reported ADRs to Indian Pharmacopoeia Commission (IPC)(Ghaziabad by using VIGIFLOW software.)

Investigators

Sponsor
Dr. Kapil Goyal
Sponsor Class
Other [self]
Responsible Party
Principal Investigator
Principal Investigator

Dr Kapil Goyal

SMS Medical College

Study Sites (1)

Loading locations...

Similar Trials